Norinchukin Bank’s Medtronic MDT Stock Holding History

Norinchukin Bank’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.66M	Buy	76,867 +212	+0.3%	+$20.3K	0.08%	146
2025 Q4	$7.36M	Buy	76,655 +4,679	+7%	+$454K	0.09%	132
2025 Q3	$6.85M	Buy	71,976 +1,541	+2%	+$142K	0.09%	132
2025 Q2	$6.14M	Buy	70,435 +3,859	+6%	+$327K	0.09%	136
2025 Q1	$5.98M	Buy	66,576 +8,797	+15%	+$787K	0.11%	124
2024 Q4	$4.62M	Buy	57,779 +4,899	+9%	+$424K	0.1%	128
2024 Q3	$4.76M	Buy	52,880 +5,930	+13%	+$499K	0.11%	120
2024 Q2	$3.7M	Buy	46,950 +795	+2%	+$65.2K	0.11%	119
2024 Q1	$4.02M	Sell	46,155 -681	-1%	-$58.1K	0.12%	115
2023 Q4	$3.86M	Sell	46,836 -4,691	-9%	-$358K	0.09%	115
2023 Q3	$4.04M	Sell	51,527 -58,618	-53%	-$4.91M	0.09%	115
2023 Q2	$9.7M	Buy	110,145 +26,113	+31%	+$2.25M	0.16%	100
2023 Q1	$6.77M	Buy	84,032 +2,644	+3%	+$215K	0.13%	107
2022 Q4	$6.33M	Sell	81,388 -18,558	-19%	-$1.5M	0.14%	108
2022 Q3	$8.07M	Buy	99,946 +10,226	+11%	+$919K	0.16%	93
2022 Q2	$8.05M	Sell	89,720 -34,687	-28%	-$3.51M	0.16%	89
2022 Q1	$13.8M	Buy	124,407 +9,153	+8%	+$967K	0.18%	89
2021 Q4	$11.9M	Sell	115,254 -573	-0.5%	-$66.4K	0.15%	96
2021 Q3	$14.5M	Buy	115,827 +4,502	+4%	+$583K	0.2%	82
2021 Q2	$13.8M	Sell	111,325 -805	-0.7%	-$101K	0.2%	79
2021 Q1	$13.2M	Buy	112,130 +1,968	+2%	+$231K	0.18%	75
2020 Q4	$12.9M	Sell	110,162 -3,469	-3%	-$382K	0.18%	75
2020 Q3	$11.8M	Buy	113,631 +1,358	+1%	+$136K	0.19%	71
2020 Q2	$10.3M	Sell	112,273 -1,104	-1%	-$106K	0.18%	74
2020 Q1	$10.2M	Sell	113,377 -104,278	-48%	-$11.1M	0.2%	71
2019 Q4	$24.7M	Sell	217,655 -16,297	-7%	-$1.79M	0.32%	57
2019 Q3	$25.4M	Buy	233,952 +4,946	+2%	+$516K	0.36%	44
2019 Q2	$22.3M	Sell	229,006 -94,594	-29%	-$8.64M	0.34%	46
2019 Q1	$29.5M	Buy	323,600 +8,590	+3%	+$769K	0.38%	50
2018 Q4	$28.7M	Buy	315,010 +72,126	+30%	+$6.74M	0.4%	46
2018 Q3	$23.9M	Buy	242,884 +19,815	+9%	+$1.83M	0.32%	52
2018 Q2	$19.1M	Buy	223,069 +3,293	+1%	+$275K	0.28%	60
2018 Q1	$17.6M	Buy	219,776 +16,848	+8%	+$1.39M	0.3%	56
2017 Q4	$16.4M	Buy	202,928 +7,270	+4%	+$582K	0.29%	56
2017 Q3	$15.2M	Buy	195,658 +30,238	+18%	+$2.51M	0.29%	56
2017 Q2	$14.7M	Buy	165,420 +6,351	+4%	+$536K	0.3%	52
2017 Q1	$12.8M	Buy	159,069 +6,076	+4%	+$475K	0.28%	57
2016 Q4	$10.9M	Buy	152,993 +9,254	+6%	+$727K	0.25%	63
2016 Q3	$12.4M	Sell	143,739 -1,197	-0.8%	-$104K	0.3%	54
2016 Q2	$12.6M	Buy	144,936 +1,912	+1%	+$155K	0.31%	55
2016 Q1	$10.7M	Buy	143,024 +6,309	+5%	+$475K	0.26%	64
2015 Q4	$10.5M	Sell	136,715 -15,191	-10%	-$1.14M	0.27%	62
2015 Q3	$10.2M	Sell	151,906 -250	-0.2%	-$18.4K	0.27%	60
2015 Q2	$11.3M	Sell	152,156 -3,518	-2%	-$269K	0.29%	53
2015 Q1	$12.1M	Buy	155,674 +47,254	+44%	+$3.58M	0.29%	51
2014 Q4	$7.83M	Buy	108,420 +19,216	+22%	+$1.33M	0.19%	71
2014 Q3	$5.53M	Buy	89,204 +1,048	+1%	+$66.6K	0.16%	70
2014 Q2	$5.62M	Sell	88,156 -10,825	-11%	-$658K	0.17%	67
2014 Q1	$6.09M	Buy	98,981 +3,891	+4%	+$227K	0.17%	68
2013 Q4	$5.46M	Sell	95,090 -313	-0.3%	-$17.7K	0.15%	70
2013 Q3	$5.08M	Buy	95,403 +1,855	+2%	+$99.8K	0.15%	70
2013 Q2	$4.82M	Buy	+93,548	New	+$4.62M	0.15%	70

Other funds holding MDT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norinchukin Bank's MDT Position: Q1 2026 in Review

Norinchukin Bank increased its Medtronic (MDT) stake by 0.28% in Q1 2026, buying an estimated $20.3K and bringing the position to 76,867 shares worth $6.66M. The position accounts for 0.08% of the portfolio, ranked #146.

Norinchukin Bank first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $29.5M in Q1 2019. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

Norinchukin Bank held 76,867 shares of Medtronic worth $6.66M as of Q1 2026.
Norinchukin Bank bought 212 Medtronic shares in Q1 2026, an estimated $20.3K.
Medtronic made up 0.08% of Norinchukin Bank's portfolio in Q1 2026, its #146 holding.
Norinchukin Bank first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
Norinchukin Bank's Medtronic position peaked at $29.5M in Q1 2019.
2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Norinchukin Bank's 13F filing for Q1 2026, filed 15 May 2026.